UK markets closed
  • NIKKEI 225

    26,153.81
    +218.19 (+0.84%)
     
  • HANG SENG

    21,830.35
    -29.44 (-0.13%)
     
  • CRUDE OIL

    110.50
    +2.07 (+1.91%)
     
  • GOLD FUTURES

    1,807.10
    +5.60 (+0.31%)
     
  • DOW

    31,097.26
    +321.86 (+1.05%)
     
  • BTC-GBP

    16,272.65
    +400.92 (+2.53%)
     
  • CMC Crypto 200

    426.97
    +6.83 (+1.63%)
     
  • ^IXIC

    11,127.84
    +99.14 (+0.90%)
     
  • ^FTAS

    3,967.61
    +27.58 (+0.70%)
     

Global Vascular Closure Devices Market to Reach $1 Billion by 2026

·28-min read
ReportLinker
ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, June 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vascular Closure Devices Industry" - https://www.reportlinker.com/p05896474/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Vascular Closure Devices Market to Reach $1 Billion by 2026

A vascular closure device is a medical device designed to provide rapid hemostasis and reduce vascular complications after percutaneous femoral access and. Vascular closure devices also improve patient comfort, reduce discomfort associated with prolonged bed rest, facilitate early patient mobilization, and decrease hospital length of stay. These devices have emerged as an effective alternative to traditional mechanical compression for femoral artery closure. Suture-based and metal clip-based vascular closure devices reduce time to hemostasis when compared with manual or mechanical compression. Vascular closure devices are being widely used in patients undergoing cardiac catheterization through femoral arterial access. Cardiovascular procedures that require catheterization include interventional procedures such as angioplasty, coronary thrombectomy and placement of a stent, and diagnostic procedures that help diagnose diseased blood vessels. Most vascular closure devices leave foreign bodies within the artery and/or surrounding soft tissues. Recent methods to close the access site involve the use of novel materials such as sealants comprised of polyethylene glycol that dissolve over a short period of time.

Amid the COVID-19 crisis, the global market for Vascular Closure Devices estimated at US$731.5 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2026, growing at a CAGR of 6.8% over the analysis period. Passive Approximators, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$783.3 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Active Approximators segment is readjusted to a revised 6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $323 Million in 2021, While China is Forecast to Reach $110.5 Million by 2026

The Vascular Closure Devices market in the U.S. is estimated at US$323 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$110.5 Million by the year 2026 trailing a CAGR of 8.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

The market is expected to witness steady growth in the long term due to the increasing number of femoral artery cardiac catheterization, the benefits of reduced hemostasis time, and enhanced patient comfort. Vascular closure devices seal femoral artery punctures in patients who have undergone interventional procedures or diagnostic angiography procedures. In countries across the world, approvals for new vascular closure devices are increasing. This combined with the other factors of rising government support and initiatives and growing demand among patients for more advanced treatment options for cardiovascular diseases is expected to result in steady growth for the market over the long term. Market players aggressively invest in research for new products which is also a major market growth driver. Another important growth driving factor is the higher efficiency rate of the new devices that have entered the market in the recent years.

In the current era where healthcare is cutting down on costs, there is a shift in focus for technologies from manual compression for hemostasis to fasten vascular closure. Although these devices increase the procedural costs, in the long run, it is cost-effective. Faster hemostasis reduces bleeding complications, saves nursing time after the procedure, increases patient throughput, quickens patient ambulation, and increases overall patient satisfaction. Further, it supports hospitals following percutaneous coronary intervention (PCI) programs. The devices are classified into three sections - vascular closure devices that instantly closes the vessel using mechanical process; compression devices that fasten onto the patient to enable pressure on the arteriotomy site; and hemostatic pads comprising materials to fasten the clotting force to lower time to hemostasis. Typically, manual compression is used in combination with hemostatic pads.

External Hemostatic Devices Segment to Reach $137.4 Million by 2026

This category comprises pads or patches and aid in the promotion of coagulation through concentrating clotting devices and factors, which exert pressure manually on the arteriotomy. With increased employment of transradial access in several centers, the use of external hemostatic devices are increasing across various settings. Due to several advantages associated with transradial access in comparison to transfemoral access. In terms of cost also, radial hemostatic devices are affordable in comparison to several VCDs, which are used after the transfemoral access. In the global External Hemostatic Devices segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.9 Million in the year 2020 will reach a projected size of US$125.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.3 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period.
Select Competitors (Total 36 Featured) -

  • Abbott Laboratories

  • Advanced Vascular Dynamics

  • Cardinal Health, Inc.

  • Cardival Medical, Inc.

  • Endocor GmbH

  • Medtronic PLC

  • Merit Medical Systems Inc.

  • Morris Innovative Inc.

  • Teleflex Incorporated

  • Terumo Corporation

  • Transluminal Technologies LLC

  • Tricol Medical Inc.

  • Vivasure Medical Ltd.




Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vascular Closure Devices - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Vascular Closure Devices - A Prelude
Benefits
Active Approximators
Passive Approximators
External Hemostatic Devices
Vascular Closure Devices to Witness Steady Growth Post COVID-19
Interventional Cardiology to Dominate the Market
Passive Approximators Lead the Market
Femoral Access Type Leads the Market
United States Holds a Dominant Share, Asia-Pacific to Witness
Rapid Growth
Competition
Growth Restraints

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Medical Device Companies Focus on Developing Advanced
Biomechanical VCDs
Increasing Demand for Large-bore Vascular Closure Devices
Select Large Bore Closure Devices
Cardiovascular Diseases: A Significant Contributor to Market
Growth
Fatalities by Heart Conditions: Estimated Percentage Breakdown
for Cardiovascular Disease, Ischemic Heart Disease, Stroke,
and Others
Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Rising Preference for Minimally Invasive Procedures Boosts
Market Prospects
Aging Population Drives Demand for Vascular Closure Devices
Expanding Elderly Population Worldwide: Breakdown of Number of
People Aged 65+ Years in Million by Geographic Region for the
Years 2019 and 2030
Life Expectancy for Select Countries in Number of Years: 2019
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years
2016 & 2018
Recent Approvals and Launches
Essential Medical Inc Receives FDA Clearance for its Large-Bore
Vascular Closure Device
Vascade MVP Vascular Closure System Obtains Approval from FDA
Large Bore PerQseal Closure Device Introduced in Europe
Cordis Introduces Mynx Control Vascular Closure Device
FDA Approves Teleflex’s Vascular Closure Device
Vasorum Set to Commercialize a New Vascular Closure Device
across the US

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Vascular Closure Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Vascular Closure Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Vascular Closure Devices
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Passive Approximators by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Passive Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Passive Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Active Approximators by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Active Approximators by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Active Approximators by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
External Hemostatic Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for External Hemostatic Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for External Hemostatic
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 13: World Recent Past, Current & Future Analysis for
Interventional Cardiology by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Interventional Cardiology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Interventional
Cardiology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 16: World Recent Past, Current & Future Analysis for
Interventional Radiology/Vascular Surgery by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Interventional
Radiology/Vascular Surgery by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Interventional
Radiology/Vascular Surgery by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Femoral by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Femoral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Femoral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Radial by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Radial by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Radial by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 25: USA Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2021 & 2027

Table 28: USA Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 30: USA 15-Year Perspective for Vascular Closure Devices
by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 31: USA Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 33: USA 15-Year Perspective for Vascular Closure Devices
by Access - Percentage Breakdown of Value Sales for Femoral and
Radial for the Years 2012, 2021 & 2027

CANADA
Table 34: Canada Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 36: Canada 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 37: Canada Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 39: Canada 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 40: Canada Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 42: Canada 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

JAPAN
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Graying Population Spurs Growth of Vascular Closure Devices
Table 24: Japanese Population by Age Group (2015 & 2040):
Percentage Share Breakdown of Population for 0-14, 15-64 and 65 &
Above Age Groups

Table 43: Japan Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 46: Japan Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Japan Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 48: Japan 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 49: Japan Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 51: Japan 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

CHINA
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 52: China Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 53: China Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: China 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 55: China Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: China Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 57: China 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 58: China Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 60: China 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

EUROPE
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Ageing Demography - An Opportunity Indicator
European Population by Age Group (2016, 2030 & 2050):
Percentage Share Breakdown by Age Group for 0-14, 15-64, and
65 & Above
Table 61: Europe Recent Past, Current & Future Analysis for
Vascular Closure Devices by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Vascular Closure Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 63: Europe 15-Year Perspective for Vascular Closure
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2021 & 2027

Table 64: Europe Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Europe Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 66: Europe 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 67: Europe Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 69: Europe 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 70: Europe Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 72: Europe 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

FRANCE
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 73: France Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 75: France 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 76: France Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: France Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 78: France 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 79: France Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 81: France 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

GERMANY
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 82: Germany Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: Germany Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 84: Germany 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 85: Germany Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Germany Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 87: Germany 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 88: Germany Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 90: Germany 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

ITALY
Table 91: Italy Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Italy Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Italy 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 94: Italy Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Italy Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 96: Italy 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 97: Italy Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 99: Italy 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

UNITED KINGDOM
Vascular Closure Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 100: UK Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 101: UK Historic Review for Vascular Closure Devices by
Type - Passive Approximators, Active Approximators and External
Hemostatic Devices Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: UK 15-Year Perspective for Vascular Closure Devices
by Type - Percentage Breakdown of Value Sales for Passive
Approximators, Active Approximators and External Hemostatic
Devices for the Years 2012, 2021 & 2027

Table 103: UK Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: UK Historic Review for Vascular Closure Devices by
Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 105: UK 15-Year Perspective for Vascular Closure Devices
by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 106: UK Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Vascular Closure Devices by
Access - Femoral and Radial Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 108: UK 15-Year Perspective for Vascular Closure Devices
by Access - Percentage Breakdown of Value Sales for Femoral and
Radial for the Years 2012, 2021 & 2027

SPAIN
Table 109: Spain Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 110: Spain Historic Review for Vascular Closure Devices
by Type - Passive Approximators, Active Approximators and
External Hemostatic Devices Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 111: Spain 15-Year Perspective for Vascular Closure
Devices by Type - Percentage Breakdown of Value Sales for
Passive Approximators, Active Approximators and External
Hemostatic Devices for the Years 2012, 2021 & 2027

Table 112: Spain Recent Past, Current & Future Analysis for
Vascular Closure Devices by Procedure - Interventional
Cardiology and Interventional Radiology/Vascular Surgery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Spain Historic Review for Vascular Closure Devices
by Procedure - Interventional Cardiology and Interventional
Radiology/Vascular Surgery Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 114: Spain 15-Year Perspective for Vascular Closure
Devices by Procedure - Percentage Breakdown of Value Sales for
Interventional Cardiology and Interventional Radiology/Vascular
Surgery for the Years 2012, 2021 & 2027

Table 115: Spain Recent Past, Current & Future Analysis for
Vascular Closure Devices by Access - Femoral and Radial -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Vascular Closure Devices
by Access - Femoral and Radial Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 117: Spain 15-Year Perspective for Vascular Closure
Devices by Access - Percentage Breakdown of Value Sales for
Femoral and Radial for the Years 2012, 2021 & 2027

RUSSIA
Table 118: Russia Recent Past, Current & Future Analysis for
Vascular Closure Devices by Type - Passive Approximators,
Active Approximators and External Hemostatic Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896474/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting